Alembic Pharmaceuticals Limited (APLLTD.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 130.36B |
| Enterprise Value | 142.64B |
| P/E Ratio | 23.22 |
| PEG Ratio | 1.46 |
| Price/Sales Ratio | 2.13 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 2.3 |
| Enterprise/EBITDA | 15.48 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 73.45B |
| Revenue/Share | 373.59 |
| Gross Profit | 33.1B |
| EBITDA | 11.06B |
| Net Income | 6.75B |
| Diluted EPS | 34.33 |
Balance Sheet
| Total Cash | 2.03B |
| Total Cash/Share | 10.31 |
| Total Debt | 14.3B |
| Total Debt/Equity | 0.25 |
| Current Ratio | 1.76 |
| Book Value Per Share | 288.34 |
Price History
| 52-Week Change | -17.6 |
| 52-Week High | 1,002 |
| 52-Week Low | 635.8 |
| Moving Average 50 Days | 784.7 |
| Moving Average 200 Days | 792.85 |
Statistics
| Average Volume | 160,311 |
| Shares Outstanding | 196.56M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 12 |
| Trailing Annual Dividend Yield | 1.51 |
| Payout Ratio | 0.32 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
